
    
      The study is prospectively conducted at 8 high-volume PCI centers in China with IVUS
      expertise. Clinic follow-up are planned in all patients 12 months after implantation of drug
      eluting stents. Primary endpoint is target vessel failure. The study is powered for primary
      endpoint, which are likely to reach significance at the level P < 0.05 even at a follow-up
      drop-out rate up to 10%.
    
  